Science
RNA markers in blood predict disease progression
In a proof-of-concept study, researchers at Imperial have tested VeloCD, a bioinformatics-based method that successfully predicts illness progression and treatment efficacy using RNA markers in blood. Their research found that the test could accurately predict disease trajectories and future infection status in controlled human challenge studies for COVID-19 and influenza.